Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant
Joint Authors
Ahmed, Zarir
Schoen, Martin
Rajeh, Nabeel
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-07-17
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Myasthenia gravis is a very rare manifestation of graft versus host disease after stem cell transplants.
Herein, we describe a case of new-onset myasthenia gravis after a stem cell transplant 34 months ago in a patient with myelodysplastic syndrome.
American Psychological Association (APA)
Ahmed, Zarir& Schoen, Martin& Rajeh, Nabeel. 2018. Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant. Case Reports in Hematology،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1143982
Modern Language Association (MLA)
Ahmed, Zarir…[et al.]. Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant. Case Reports in Hematology No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1143982
American Medical Association (AMA)
Ahmed, Zarir& Schoen, Martin& Rajeh, Nabeel. Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant. Case Reports in Hematology. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1143982
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1143982
